Can the ACL Actually Heal Without Surgery?
The Ask Mike Reinold podcast examined the cross‑bracing protocol, a non‑operative approach that immobilizes the knee in 90 degrees flexion for about four weeks to allow an ACL tear to heal. Recent Australian studies report roughly a 30 percent success rate, while a 2026 Clinical Journal of Sports Medicine paper found a 70 percent re‑tear rate when the brace is applied later than the first week. Clinicians remain skeptical, noting the protocol’s suitability mainly for proximal avulsion tears and highlighting risks such as blood clots, stiffness, and uncertain long‑term stability. The discussion underscores the need for careful patient selection versus traditional reconstruction.
Pharma Pulse: TrumpRx Goes Generic and the FDA Loses More Leaders
The Trump administration expanded TrumpRx.gov to feature more than 600 generic drugs, using price aggregation and tariff exemptions for 17 manufacturers to target $64.3 billion in savings over ten years. The Supreme Court declined to hear industry challenges, leaving Medicare drug‑price...
Looking for a Lifeline: New Compounds Show Promise Against AMR
Scientists at Umeå University have created a new class of synthetic tricyclic compounds, called TriPcides, that effectively kill MRSA strains resistant to earlier GmPcide antibiotics. By redesigning the molecular scaffold to evade the lmrB efflux pump, the compounds prevent the...
Huawei Xinghe Intelligent High-Quality Hospital Network: Empowering Global Smart Healthcare Development
Huawei introduced the Xinghe Intelligent Campus Network, a full‑stack solution that combines Wi‑Fi 7 zero‑roaming, high‑quality optical Ethernet, Twins dual‑engine switches and AI‑driven SDN control. The platform delivers uninterrupted 24/7 connectivity, sub‑second failover and proactive fault prediction for hospitals worldwide. By...
Workflow First Digital Strategy
Healthcare digital transformation remains a top priority but often fails due to misaligned technology and clinical workflows. A World Economic Forum survey shows 90% of executives prioritize digital change, yet McKinsey finds 75% lack sufficient funds or planning. Investments concentrate...
Sharp Rise in Number of Parents Refusing Newborn Vitamin K Shots, Putting Babies at 81-Fold Higher Risk of Severe Bleeding
A new JAMA study shows 5.2% of U.S. newborns in 2024 did not receive the recommended vitamin K injection, up from 2.9% in 2017 – a 77% increase. Infants who miss the shot face an 81‑fold higher risk of vitamin...
How Civic Engagement Empowers Health Care Workers
Physicians are urging a shift beyond bedside care to active civic participation, arguing that health outcomes are deeply tied to policy decisions. Evidence links low voting rates to poorer health, and primary care settings can foster community empowerment. The Civic...
Fujifilm and mTuitive Link Structured Pathology Reporting to Enterprise Imaging in New Partnership
Fujifilm Healthcare Americas and mTuitive have launched a partnership that links mTuitive’s CAP‑compliant synoptic pathology reporting platform directly to Fujifilm’s Synapse Pathology PACS. The integration streams structured pathology data—including biomarker and cancer registry fields—through the laboratory information system into the...
Ebola Is Spreading. Why Isn't America Responding?
A new Ebola outbreak of the Bundibugyo strain has erupted in Ituri Province, DRC, with 336 suspected cases and 87 deaths, including a cross‑border infection in Kampala. The United States has not deployed its former Disaster Assistance Response Team (DART)...
FDA’s Megha Kaushal ASGCT Talk: PFDD, Patient Voices, Decision-Making
At the 2026 ASGCT meeting, FDA Acting Deputy Director Megha Kaushal highlighted the agency’s Patient‑Focused Drug Development (PFDD) initiative, urging early integration of patient and caregiver input into cell and gene therapy trials. She emphasized that families’ lived‑experience data should inform...
FDA Approves New Guardant360 Liquid CDx, the Largest FDA-Approved Liquid Biopsy Panel with a 100x Expanded Footprint
Guardant Health announced FDA approval of Guardant360® Liquid CDx, the largest liquid‑biopsy panel on the market, featuring a 100‑fold expanded genomic footprint. The test merges genomic and epigenomic profiling from a single blood draw, delivering several‑fold higher circulating tumor DNA...
IntraBio Receives Regulatory Authorization to Begin Pivotal Phase III Trial of Levacetylleucine in CACNA1A-Related Disorders Across Participating Regions
IntraBio announced regulatory authorization to launch its pivotal Phase III trial of levacetylleucine (AQNEURSA) in CACNA1A‑related disorders across the United States, United Kingdom, European Union and Switzerland. The 12‑week, randomized, double‑blind, placebo‑controlled crossover study will be conducted at twelve multinational sites...
Leading NCI-Designated Cancer Centers Across the Country Leverage ConcertAI’s CancerLinQ to Support Personalized, Evidence-Based Quality Care
ConcertAI announced that the University of Rochester Medicine Wilmot Cancer Institute and UCHealth/University of Colorado Anschutz Cancer Center have joined its CancerLinQ network. The addition expands the platform’s real‑world evidence reach to over 900 sites across all 50 states. CancerLinQ’s...
The Foundation for the National Institutes of Health Announces Recipients of the Deeda Blair Research Initiative for Disorders of the...
The Foundation for the National Institutes of Health announced three new awardees of the Deeda Blair Research Initiative for Disorders of the Brain. Each will receive $200,000 to fund innovative projects aimed at transforming diagnosis and treatment of severe mental...
Incyte and Genesis Expand Molecular AI Collaboration to Accelerate Drug Discovery
Incyte and Genesis Molecular AI have broadened their partnership, granting Genesis access to Incyte's proprietary experimental data to train the next‑generation GEMS AI platform. The deal includes a $120 million upfront payment—$80 million in cash and $40 million in equity—plus recurring research funding....
Where Your Out-of-the-Box eQMS Is Probably Underbuilt
Clinical‑stage companies are discovering that eQMS platforms purchased two years ago often fall short of 21 CFR Part 11 requirements. Vendors typically oversell out‑of‑the‑box functionality, leaving audit trails incomplete and access controls too permissive. The gaps become evident only after a...
Derbyshire NHS Selects Psyomics’ Beseen Platform to Support Community Mental Health Transformation
Derbyshire Healthcare NHS Foundation Trust has partnered with digital‑mental‑health specialist Psyomics to deploy its beseen Adult platform across Community Mental Health Teams. The solution automates patient‑reported outcome collection, integrates directly with the Trust’s electronic health records, and aims to ease...
Medicine by Captivity: The Rise of the Hostage Physician
Dr. Joseph Varon’s firsthand account illustrates how U.S. hospitals have become industrial‑scale systems where insurance deadlines and occupancy metrics dictate patient care. He describes ICU overcrowding, staff exhaustion, and administrators pressuring physicians to consider the "insurance clock" rather than clinical...
Video Wednesday
Neuralink showcased a new surgical robot that can insert hundreds of ultra‑fine, flexible threads, each carrying thousands of electrodes, into targeted neurons with micron‑level precision. The system actively avoids blood vessels and adapts to real‑time brain motion, minimizing tissue trauma....
‘Really Bad Blow’: U.S. Supreme Court Won’t Hear Los Angeles Schools COVID Vaccine Case
On Monday, the U.S. Supreme Court refused to hear an appeal challenging the Los Angeles Unified School District’s COVID‑19 vaccine mandate, effectively leaving the 9th Circuit Court of Appeals’ en banc decision in place. The lower court had upheld the...
Taiwan’s AI-Driven Clinical Breakthroughs Take Centre Stage at 2026 Taiwan Smart Medical & HealthTech Expo in Geneva
The 2026 Taiwan Smart Medical & HealthTech Expo in Geneva highlighted Taiwan’s transition from AI theory to bedside practice, showcasing a national team of 21 firms and nine leading hospitals. Clinical evidence included a Nature Medicine‑published AI‑ECG trial that cut...
ADAA’s Vision for Anxiety and Depression Care in 2026 and Beyond
The Anxiety & Depression Association of America (ADAA) outlined its 2025‑2028 strategic plan, emphasizing brand elevation, evidence‑based practice, and deeper member engagement. Recent milestones include the launch of the open‑access Journal of Mood and Anxiety Disorders and the rollout of...
Canagliflozin - Another Top Longevity Drug
A small, exploratory randomized trial tested dapagliflozin, an SGLT2 inhibitor, in early‑stage Alzheimer’s disease. The primary endpoint—magnetic resonance spectroscopy measurement of brain N‑acetylaspartate—showed no significant difference versus placebo. Nonetheless, the drug markedly increased systemic glucose disposal, confirming its expected metabolic...
You Can Pry My Lamictal From My Cold, Dead Hands
A new policy championed by RFK Jr. seeks CMS reimbursement for clinicians’ time spent deprescribing antidepressants, addressing a long‑standing financial barrier. The STAT analysis notes that while the reimbursement model aligns with evidence, successful implementation also requires drug‑specific tapering protocols,...
Dor Skuler, Intuition Robotics: Meet ElliQ
Intuition Robotics CEO Dor Skuler showcased ElliQ, an AI‑driven companion robot aimed at senior citizens. In a candid interview, Skuler highlighted ElliQ’s conversational abilities, health‑reminder functions, and its cultural references that resonate with older users. Medicaid programs in New York...
When Algorithms Decide Who Gets Health Care
Law professor Jennifer D. Oliva warns that AI‑powered coverage algorithms used by insurers to approve, deny, or limit care operate without FDA‑type safety testing. Her analysis shows that nearly one‑in‑five insured Americans experience claim denials, with 82% of physicians observing...
Financial Incentives, over Diagnosis, and Weak Oversight: Autism Claims Are Driving up Medicare Costs
A recent analysis reveals that Medicaid spending on applied behavior analysis (ABA) therapy for autism has exploded, rising 561% to over $2.2 billion across eight states. The surge is driven by massive overdiagnosis, with prevalence estimates inflating from 1 in 150...
Greek Courts Deliver Landmark Justice: State Held Liable for COVID Shot Harms
Greek administrative courts have begun holding the Hellenic Republic liable for COVID‑19 vaccine injuries, ordering $324,000 in compensation to a family after a woman died from AstraZeneca‑induced thrombosis with thrombocytopenia syndrome (TTS). The decision builds on a 2025 ruling that...
New York Governor Signs Bills To Preserve Mandatory Vaccines
New York Governor Kathy Hochul signed two bills that separate the state’s vaccine requirements from federal approval, mandating that children receive shots such as measles and hepatitis B based on New York health‑commissioner guidance. The legislation also obligates health insurers to...
Pharmaceutical Executive Daily: TrumpRx Expands to Offer Over 600 Generic Drugs
The Trump administration has broadened TrumpRx to include more than 600 generic drugs for chronic illnesses such as diabetes, hypertension and high cholesterol. The platform now integrates price‑comparison tools and links with Cost Plus Drugs, Amazon Pharmacy and GoodRx, letting cash‑pay patients...
EndoQuest Advances Multicenter PARADIGM Trial with Completion of Procedures at Baylor St. Luke’s Medical Center
EndoQuest Robotics announced that Baylor St. Luke’s Medical Center has become an active site in its multicenter PARADIGM trial, successfully completing its first robotic endoscopic submucosal dissection (ESD) procedures using the Endoluminal Surgical (ELS) System. The trial, which evaluates safety and...
DNAnexus Scales AI-Driven Capabilities
DNAnexus unveiled a suite of AI‑driven tools that turn massive multi‑omic datasets into enterprise‑grade AI assets. The GenAI‑powered Omics Data Agent lets researchers query complex data with natural language, while the AutoML Assistant promises up to an 80% reduction in...
Nourish Raises $100M Series C to Reverse Chronic Disease with AI-Native Metabolic Clinic
Nourish, the nation’s largest dietitian‑led metabolic health clinic, announced a $100 million Series C round, lifting its total capital to $215 million. The funding, led by Menlo Ventures and joined by a slate of top venture firms, will expand its AI‑native clinic network,...
How LIMS Supports GMP Compliance
Laboratory Information Management Systems (LIMS) are transitioning from simple workflow tools to essential infrastructure for Good Manufacturing Practice (GMP) compliance across regulated sectors such as pharma, medical devices, cannabis and nicotine products. By embedding audit trails, electronic signatures, version control...
The Bill That Never Ends
Jeni Rae Peters, a single mother with employer‑provided insurance, accrued at least $30,000 in medical debt while treating stage‑2 breast cancer, illustrating how high‑deductible plans can bankrupt patients even when they are covered. A 2024 American Cancer Society survey found...
Doximity Unbound
Doximity announced a rapid series of strategic moves, including renaming its DoxGPT chatbot to “Ask,” launching free e‑prescribing through a Surescripts partnership, and embedding its AI tools in Aledade’s large value‑based care network. These initiatives are packaged as a Clinical...
Wolters Kluwer Provides MDS Solution Medi-Span to The Christie NHS Foundation Trust
Wolters Kluwer Health has rolled out its Medi‑Span medication decision‑support platform at The Christie NHS Foundation Trust, the largest single‑site cancer centre in Europe. The solution is embedded within the Better Meds ePMA system, delivering real‑time allergy and drug‑interaction alerts directly into...
TAVR Day: What to Do and When to Do It
Transcatheter aortic valve replacement (TAVR) volumes have more than tripled over the past decade, driving a rapid expansion of the sonographer’s responsibilities. While most echocardiography education concentrates on post‑procedure follow‑up, the day‑of‑procedure imaging—baseline, intra‑procedural, and immediate post‑deployment—directly influences complication detection....
3D Printing for All: Lessons From Hospitals That Built It From the Ground Up
Materialise’s recent forums highlighted how district hospitals are turning point‑of‑care 3D printing from a niche experiment into an operational service. At RUH Bath, a single printer was added to solve a logistics issue, then expanded to surgical planning and custom...
Ovarian Cancer Clinical Trials: How Patient-Centered Design Can Improve Late-Line Study Enrollment
Genelux is advancing Olvi-Vec, an oncolytic immunotherapy, in late‑line ovarian cancer with a Phase III OnPrime trial that compares Olvi-Vec plus chemotherapy to physician’s choice. The Phase II VIRO‑15 study reported a 54% objective response rate, 11‑month median progression‑free survival...
Viewpoint: ‘Crisis of Public Trust’: Autism Support Community Shocked RFK Continues to Peddle False Claims About the Danger of Vaccines
A newly released report urges Congress to hold oversight hearings and consider impeachment of officials such as Robert F. Kennedy Jr. for perpetuating vaccine misinformation. The report highlights a federal push to tie autism to prenatal acetaminophen use and the replacement of the...
Testosterone Shots: SubQ or IM?
A 2022 head‑to‑head trial of 234 hypogonadal men compared weekly intramuscular testosterone cypionate with subcutaneous testosterone enanthate. Both routes achieved equivalent total testosterone levels, but the subcutaneous group showed significantly lower post‑therapy estradiol and hematocrit. The flatter absorption curve of...
Developing a Drug To Reverse Heart Disease
Repair Biotechnologies’ lead candidate, REP-0004, is an mRNA‑based lipid nanoparticle designed to deliver a cholesterol‑degrading protein exclusively to hepatocytes. The FDA granted the drug orphan‑drug status and the company targets a Phase 1 start by mid‑2027, pending GMP manufacturing and IND‑enabling...
Reclaiming the Lost Art of the Physical Exam
Ann Lebeck’s essay warns that modern medicine’s focus on imaging and referrals is eclipsing the foundational skill of careful physical observation. She argues that subtle cues—gait, posture, guarded movements—often precede diagnostic findings and can guide more accurate, cost‑effective care. While technology...
Adenine Base Editing Demonstrates Profound Impact on Rare Disease
Researchers at The Jackson Laboratory used adenine base editing to repair the SCN1A R613X mutation that causes Dravet syndrome in mice. A single brain injection corrected roughly 60% of the defective DNA, restoring normal gene expression and dramatically reducing seizures....
Quantori and Knowledge3 Announce Co-Marketing Partnership to Advance Knowledge-Driven AI in Life Sciences
Quantori, a digital transformation firm for life sciences, announced a co‑marketing partnership with Knowledge3, a specialist in knowledge graphs and FAIR data. The alliance blends Quantori’s AI and scientific software expertise with Knowledge3’s knowledge‑first architecture to create scalable, context‑aware AI...
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
The FDA has granted approval to Baxfendy (baxdrostat), AstraZeneca’s first aldosterone synthase inhibitor, for adults whose blood pressure remains uncontrolled despite existing therapies. The approval is based on the phase 3 BaxHTN trial, where a 2 mg dose lowered systolic pressure by...
Kaleidex Announces Major New MedTech Manufacturing Facility in Yorkshire
Kaleidex Group announced Kaleidex One, a 60,000 sq ft precision‑manufacturing hub in Yorkshire slated for a 2027 launch. The "Factory of the Future" will combine clean‑room assembly, rapid prototyping, automation and end‑to‑end production services for global OEMs and emerging MedTech firms. It...
Cambridge-Derived Brain Health Company Prema Cognition Closes Oversubscribed Funding Round to Advance Early Dementia Detection
Prema Cognition, a Cambridge‑derived digital health firm, closed an oversubscribed £550,000 (~$700,000) funding round led by SFC Capital, surpassing its £500,000 target. The capital will expand clinical datasets, accelerate regulatory work, and drive global rollout of its PREMAZ platform, which...
Cognitive Overload in Cardiac Arrest Is a Human Problem
Dr. Michael Peck highlights that clinicians managing cardiac arrests still depend heavily on memory, leading to cognitive overload during high‑stress resuscitations. Over three decades of technological advances have not addressed this human limitation, prompting him and an emergency‑medicine co‑founder to...